跳至主要内容
临床试验/NCT07164417
NCT07164417已完成不适用

Comparing Two Types of PRF Membranes in Management of Dehiscence Defect With Simultaneous Implant Placement in Posterior Mandible (Randomized Controlled Clinical Trial)

Alexandria University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Change in implant stability

研究概览

简要总结

Background: Placement of implants in an atrophic posterior ridge is a challenge for so many clinicians. The success of dental implants depends on the volume of alveolar bone available to provide stability. Bone grafting using xenograft with PRF and e-PRF as a membrane has shown promising results in both bone healing and defect reconstruction. Aim of the study: to evaluate the effect of Platelet-rich fibrin (PRF) and Extended Platelet-rich fibrin (e-PRF) as a membrane with xenograft to increase the width of ridge in posterior mandible with simultaneous implant placement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient with one or more missing posterior mandibular teeth.
  • •Patient with atrophic posterior mandible with residual ridge width in the range of 4 to 6mm.
  • •Patient with good oral hygiene and acceptable inter-arch space less than or equal to the restoration

排除标准

  • •The patient underwent alveolar ridge reconstruction in the same area.
  • •Patients with immune diseases, uncontrolled hypertension, and uncontrolled diabetes.
  • •Patient with any pathological condition at the site of surgery.
  • •Heavy smoker, alcohol abuse, parafunctional habits.

研究组 & 干预措施

PRF

Active Comparator

干预措施: PRF membrane will be used with xenograft simultaneously with implant placement (Other)

e-PRF

Experimental

干预措施: e-PRF membrane will be used with xenograft simultaneously with implant placement. (Other)

结局指标

主要结局

Change in implant stability

时间窗: baseline and 6 months

Osstell device will be used to measure the implant stability, primary stability Just after implant placement, and secondary stability 6 months from the time of implant placement. The measured values will be recorded in ISQ from 1 to 100, Implant stability is directly proportional to ISQ value

次要结局

  • change in pain scores(uo to 7 days)
  • Change in edema scores(up to 7 days)
  • change in bone width gain(baseline and 6 months)
  • change in bone density(baseline and 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验